Promensil Menopause Double Strength 60s

Promensil Menopause Double Strength helps relieve menopausal symptoms in post menopausal women including hot flushes, night sweats and mild anxiety.

Always read the label. Follow the directions for use. If symptoms persist, talk to your health professional. Contains soya.

Where To Buy

Features and benefits

What is Promensil Menopause Double Strength for?
Helps relieve the symptoms of menopause in post menopausal women including night sweats, hot flushes, mild anxiety and moodiness.

Who is Promensil Menopause Double Strength Tabs for?
Women experiencing menopause symptoms. Promensil is a supplement based on Red Clover isoflavones specifically standardised to help maintain general wellbeing for women after menopause.

When should I take Promensil Menopause Double Strength Tabs?
For the relief of menopause symptoms in post menopausal women.

Why should I take Promensil Menopause Double Strength Tabs?
Promensil Menopause Double Strength has twice the amount of isoflavones (derived from Red clover), a unique ingredient of natural standardised red clover isoflavones which can help relieve the symptoms of menopause including night sweats, hot flushes and mild anxiety in post-menopausal women.

1 tablet daily with a meal. While individual responses vary, many women will notice difference in symptoms within 3-8 weeks of daily usage.

STORAGE INSTRUCTIONS

Store below 30°C in a dry place away from direct sunlight.

Dosage Form: Film coated tablet
Quantity: 60 tablets
Active ingredients per tablet: Contains standardised extract equivalent to dried Trifolium pratense herb 5g (equiv. isoflavones 80mg)

Active Ingredients: Trifolium pratense (Red Clover) herb ext. dry conc. std. 200 mg equiv. to dry herb 5g (min) equiv. to Isoflavones (of Trifolium pratense) 80 mg per tablet.

Sign up to our newsletter today and receive emails with all the latest menopause news and promotions.

Always read the label. Follow the directions for use. If symptoms persist, talk to your health professional.